showed a trendp = 0.069
The reduced model (lacking the interaction term) showed a trend towards shorter pieces being made when the template was short (estimate = − 1.049, SE ± 0.489, χ 2 = 3.310, p = 0.069).
The reduced model (lacking the interaction term) showed a trend towards shorter pieces being made when the template was short (estimate = − 1.049, SE ± 0.489, χ 2 = 3.310, p = 0.069).
Although the reduction in food intake was not reflected in the body weight, the cumulative gain in body weight of virgin females fed WPI (3.84 ± 0.37 g) showed a trend towards a decrease compared to the controls fed CAS (5.2 ± 0.62g ) over the 11 weeks ( p = 0.069).
Comparing the groups with and without dysphagia, the female gender was the only clinical parameter that showed a trend of statistical significance in the group with dysphagia ( p = 0.069).
The Bonferroni test showed a trend-significant difference p = 0.069 between emergency department and the COVID ward/station, with the stress-protective effects being greatest for staff on the COVID ward.
The composite of all-cause death/HFH showed a trend for fewer events in the Telmisartan compared to Enalapril, with a rate of 8 (18.2%) versus 16 (34%), p = 0.069.
This analysis showed a trend towards a 3-way interaction between Native Language, List Length, and Response Type, F (2,146) = 2.73 p = .069, η p 2 = 0.003.
Moreover, the IPMN cases with intestinal subtype showed a trend of higher values of GNAS mutant allele frequencies in their cfDNA than those with other subtypes ( P = 0.069, Fig. 4 ).
The nadir time at T OD showed a trend toward delay, more evident for cortisone (from 20:10 [15:06-01:13] to 00:14 [21:10-03:18], P = .069).
As for DLCO, the difference between six months and the end of RT showed a trend (two‐sided Pearson correlation P ‐value = 0.069).
In long-term follow-up (up to 20 years), “C-peptide negative” patients had significantly improved survival ( P = 0.019); “C-peptide positive” recipients showed a trend to better survival ( P = 0.069).
APOE analysis in plasma from the discovery cohort (n = 12) showed a trend of over-expression in ALS-fast compared to ALS slow which did not reach significance (data not shown; p = 0.069).
Additionally, poor adherence showed a trend towards increased odds in acquiring HIV-DRM (aOR = 3.72; 95% CI 0.90–15.34; P = 0.069).
Living with a single parent (separated, widowed or divorced) showed a trend towards a link with the time to dropout ( p = 0.069).
All of these differences reached statistical significance ( P<0.05 ) except for MHC in the MPred group, which showed a trend in the same direction (52% lower than Control, P = 0.069 ).
In a test of simple effects, PCOLCE was not significantly associated with discharge NIHSS in men (b = − 0.39, 95% CI: − 1.01 to 0.23, p = .217), but higher expression showed a trend toward higher NIHSS scores in women (b = 0.48, 95% CI: − 0.04 to 1.00, p = .069).
The 12 mg/m 2 dose reduced the number of T2‐weighted lesions at month 24 ( p = 0.027) and showed a trend at month 12 ( p = 0.069).
Furthermore, although no significant differences were recorded according to sex, the distance between the SGN and the apex of the GT showed a trend towards being smaller in females ( p = 0.069), possibly due to the generally smaller stature of females compared to males, which is corroborated by the data from our sample.
While pain severity, as measured by VAS scores, showed a trend toward longer hospital stays, this association was not statistically significant ( p = 0.069).
Conversely, age > 60 years was an independent predictor of achieving MCID for pain improvement (OR 1.67, 95% CI 1.12–2.48, p = 0.021) and showed a trend for ADL improvement (OR 1.45, p = 0.069).
Results FAST correlated with cravings for sweets ( r = 0.381, p = 0.034) and showed a trend for overall cravings ( r = 0.331, p = 0.069).
Notably, the addition of LDL557 extracts mitigated the MIA-induced increases in IL-1β and TNF-α expression and showed a trend toward increasing IL-10 expression (M versus M+LDL557, p = 0.06914, Figure 5 D).
CCR9 −/− mice showed a trend to develop less tumors than CCR9 +/− mice (p=0.0693) ( Fig 1E , F ) and developed significantly less tumors of 2–3 mm in size ( Fig 1F ), indicating that expression CCR9 may favor colon cancer development.
Although adult Scn2a +/− mice showed a trend towards significant slower acquisition latencies on day1–4 (two-way repeated measures ANOVA, F(1, 29) = 3.56, p = 0.0693 for genotype (borderline significance); F(5, 145) = 90.04, p < 0.0001 for day; F(5, 145) = 1.1, p = 0.3813 for genotype × day interaction), their performances were comparable to wild-type mice during the probe tests on days 5 and 12.
Sham-irradiated male APP;E4F mice showed a trend towards fewer microhemorrhages than their non-traveled counterparts ( Figure 3 B, p = 0.0693).
Serum levels across all cases (mutation carriers and non-carriers) showed a trend for correlation with plasma levels, r = 0.67, p = 0.0696 (Supplementary Fig. 3 ).